SANDFORD D SMITH Insider Trading $SNCA PALISADE BIO, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for SANDFORD D SMITH.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of SANDFORD D SMITH. SANDFORD D SMITH is Director in ARIAD PHARMACEUTICALS INC ($ARIA) and Director in QLT INC/BC ($QLTI) and Director in APRICUS BIOSCIENCES, INC. ($APRI) and Director in CYTOKINETICS INC ($CYTK) and Chief Executive Officer in Aegerion Pharmaceuticals, Inc. ($AEGR) and Director in Aegerion Pharmaceuticals, Inc. ($AEGR) and Director in Neuralstem, Inc. ($CUR) and Director in AKCEA THERAPEUTICS, INC. ($AKCA).

SANDFORD D SMITH in PALISADE BIO, INC.

Trading Symbol: SNCA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of SANDFORD D SMITH: Director
Holdings: 219,916 shares
Current Value: $664,146
Latest Transaction: Jul 03 2019
$SNCA Market Capitalization: $28.01M
$SNCA Previous Close: $3.02

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of SANDFORD D SMITH in PALISADE BIO, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AEGR, AKCA, ARIA, CYTK, NVLN, SNCA, SEEL

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 03 2019CURNeuralstem, Inc.SMITH SANDFORD DDirectorGrantA0.00166,6670219,91653.2 K to 219.9 K (+313.00 %)
Jul 05 2018CURNeuralstem, Inc.SMITH SANDFORD DDirectorGrantA0.0045,046050,8995.9 K to 50.9 K (+769.62 %)
Jul 18 2017CURNeuralstem, Inc.SMITH SANDFORD DDirectorOption ExerciseA0.009,31109,311
Jul 06 2015CURNeuralstem, Inc.SMITH SANDFORD DDirectorGrantA0.00106,9520106,9520 to 107 K

Page:   1